CHA News Article

FDA Authorizes New Zika Virus Diagnostic Tool for Emergency Use

The U.S. Food and Drug Administration (FDA) last week issued an emergency use authorization for a Zika virus diagnostic tool that will be distributed to qualified laboratories. The Centers for Disease Control and Prevention (CDC) will begin distributing the test during the next two weeks to qualified laboratories in the Laboratory Response Network; the test will not be available in U.S. hospitals or other primary care settings. The tool — Trioplex Real-time RT-PCR Assay — allows doctors to tell if an individual is currently infected with chikungunya, dengue, or Zika using one test, instead of having to perform three separate tests to determine which infection a patient might have. More information is available on the CDC website